dc.contributor.author |
Schache, KR |
|
dc.contributor.author |
Hofman, PL |
|
dc.contributor.author |
Serlachius, AS |
|
dc.coverage.spatial |
England |
|
dc.date.accessioned |
2022-08-08T04:26:00Z |
|
dc.date.available |
2022-08-08T04:26:00Z |
|
dc.date.issued |
2020-08 |
|
dc.identifier.citation |
(2020). Diabetic Medicine, 37(8), 1352-1356. |
|
dc.identifier.issn |
0742-3071 |
|
dc.identifier.uri |
https://hdl.handle.net/2292/60710 |
|
dc.description.abstract |
<h4>Aim</h4>Cost-effective psychosocial interventions that can feasibly be implemented into busy clinical settings are needed to improve psychological and physical health outcomes in adolescents with Type 1 diabetes. We examined the efficacy of a gratitude journalling intervention to improve psychological well-being and glycaemic control in adolescents aged 10-16 years with Type 1 diabetes.<h4>Methods</h4>Eighty adolescents were randomized to the 8-week gratitude intervention (N = 40) or standard care (N = 40). Self-reported measures of stress, quality of life, self-care, depression and gratitude were assessed at baseline and 8 weeks after baseline. Glycaemic control (HbA<sub>1c</sub> ) was assessed at baseline and 12 weeks after baseline. A per-protocol analysis was conducted with the adolescents who completed all questionnaires (N = 60). Analysis of covariance (ANCOVA) was used to examine differences between treatment arms at follow-up adjusting for baseline scores.<h4>Results</h4>There was no evidence of any between-group differences in the psychological or behavioural measures at follow-up (all P-values > 0.05). Glycaemic control slightly increased in the control group while remaining stable in the gratitude group, with a between-group difference of 6.1 mmol/mol [95% confidence interval (CI) -2.6 to 14.7; 0.6%, 95% CI -0.2 to 1.3] at 12 weeks after baseline. After adjusting for baseline HbA<sub>1c</sub> , this between-group difference was significant (P = 0.048).<h4>Conclusions</h4>This is the first randomized trial of a gratitude journalling intervention for adolescents with Type 1 diabetes. Gratitude journalling interventions represent a clinically usable approach. If and how it helps to stabilise glycaemic control in adolescents with Type 1 diabetes remains to be confirmed in future research. |
|
dc.format.medium |
Print-Electronic |
|
dc.publisher |
Wiley |
|
dc.relation.ispartofseries |
Diabetic medicine : a journal of the British Diabetic Association |
|
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
|
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
|
dc.subject |
Humans |
|
dc.subject |
Diabetes Mellitus, Type 1 |
|
dc.subject |
Pilot Projects |
|
dc.subject |
Depression |
|
dc.subject |
Stress, Psychological |
|
dc.subject |
Quality of Life |
|
dc.subject |
Adolescent |
|
dc.subject |
Child |
|
dc.subject |
Female |
|
dc.subject |
Male |
|
dc.subject |
Glycated Hemoglobin A |
|
dc.subject |
Psychosocial Intervention |
|
dc.subject |
Comparative Effectiveness Research |
|
dc.subject |
Diabetes |
|
dc.subject |
Clinical Research |
|
dc.subject |
Mental Health |
|
dc.subject |
Clinical Trials and Supportive Activities |
|
dc.subject |
Prevention |
|
dc.subject |
Behavioral and Social Science |
|
dc.subject |
Metabolic and endocrine |
|
dc.subject |
Science & Technology |
|
dc.subject |
Life Sciences & Biomedicine |
|
dc.subject |
Endocrinology & Metabolism |
|
dc.subject |
ADHERENCE |
|
dc.subject |
BEHAVIOR |
|
dc.subject |
STRESS |
|
dc.subject |
CARE |
|
dc.subject |
Social Sciences |
|
dc.subject |
Psychology, Multidisciplinary |
|
dc.subject |
Psychology |
|
dc.subject |
1117 Public Health and Health Services |
|
dc.subject |
1701 Psychology |
|
dc.subject |
1103 Clinical Sciences |
|
dc.subject |
Clinical |
|
dc.subject |
Public Health |
|
dc.title |
A pilot randomized controlled trial of a gratitude intervention for adolescents with Type 1 diabetes. |
|
dc.type |
Conference Item |
|
dc.identifier.doi |
10.1111/dme.14078 |
|
pubs.issue |
8 |
|
pubs.begin-page |
1352 |
|
pubs.volume |
37 |
|
dc.date.updated |
2022-07-29T02:30:54Z |
|
dc.rights.holder |
Copyright: The authors |
en |
dc.identifier.pmid |
31315150 (pubmed) |
|
pubs.author-url |
https://www.ncbi.nlm.nih.gov/pubmed/31315150 |
|
pubs.end-page |
1356 |
|
pubs.publication-status |
Published |
|
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.elements-id |
741105 |
|
pubs.org-id |
Liggins Institute |
|
pubs.org-id |
Medical and Health Sciences |
|
pubs.org-id |
School of Medicine |
|
pubs.org-id |
Psychological Medicine Dept |
|
dc.identifier.eissn |
1464-5491 |
|
pubs.record-created-at-source-date |
2022-07-29 |
|
pubs.online-publication-date |
2019-08-04 |
|